FETTERMAN & ASSOCIATES
Celebrex Attorneys
Palm Beach - West Palm Beach - Florida
CELEBREX
Pfizer manufactures Celebrex. The Food and Drug Administration approved Celebrex for sale in the United States in December of 1998. Celebrex works by targeting the COX-2 enzyme, which plays a key role in arthritis pain and inflammation. Celebrex, and other COX-2–specific inhibitors such as Vioxx and Bextra, treat the pain, inflammation, and stiffness that accompanies osteoarthritis and adult rheumatoid arthritis. Celebrex was the first of these COX-2 inhibitor drugs to gain FDA approval.
Recently, the National Cancer Institute discontinued a study of Celebrex upon indications that patients receiving 400 milligrams of Celebrex were 2.5 times more likely to have a heart attack or stroke while patients receiving 800 milligrams of Celebrex a day were 3.4 times more likely to experience serious cardiovascular events.
Despite these indications, Pfizer has chosen not to pull Celebrex off the market. Instead, Pfizer has halted a number of marketing efforts while the FDA has advised physicians to prescribe Celebrex alternatives.
Fetterman & Associates are experienced Florida pharmaceutical litigation attorneys. We represent people in Palm Beach, West Palm Beach and throughout Florida who have been injured by Celebrex.
If you or a loved one has suffered a heart attack as a result of Celebrex, call Fetterman & Associates at (561) 845-2510 or (800) 330-HELP (4357) or submit an online questionnaire. The initial consultation is free of charge, and if we agree to handle your case, we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations so please call right away to ensure that you do not waive your right to possible compensation.
|
